Antiangiogenic drugs as a novel anticancer therapeutic strategy - Which are the more promising agents? What are the clinical developments and indications?

被引：16

作者：

Gasparini, G ^{[1
]}

机构：

[1] Azienda Osped Bianchi Melacrino Morelli, Div Oncol, I-89100 Reggio Calabria, Italy

来源：

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 1997年 / 26卷 / 03期

关键词：

D O I：

10.1016/S1040-8428(97)10001-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：147 / 162

页数：16

共 122 条

[111]

Vokes Everett E., 1997, Lancet (North American Edition), V349, P4

[112] Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats [J].

Volpert, OV ;

Ward, WF ;

Lingen, MW ;

Chesler, L ;

Solt, DB ;

Johnson, MD ;

Molteni, A ;

Polverini, PJ ;

Bouck, NP .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :671-679

[113]

VUKANOVIC J, 1995, CANCER RES, V55, P1499

[114]

VUKANOVIC J, 1993, CANCER RES, V53, P1833

[115]

VUKANOVIC J, 1995, CANCER RES, V55, P3517

[116] CAPTOPRIL INCREASES SKIN MICROVASCULAR BLOOD-FLOW SECONDARY TO BRADYKININ, NITRIC-OXIDE, AND PROSTAGLANDINS [J].

WARREN, JB ;

LOI, RK .

FASEB JOURNAL, 1995, 9 (05) :411-418

[117]

WATSON SA, 1995, CANCER RES, V55, P3629

[118]

WEINSTATSASLOW DL, 1994, CANCER RES, V54, P6504

[119] ANGIOSTATIC ACTIVITIES OF MEDROXYPROGESTERONE ACETATE AND ITS ANALOGS [J].

YAMAMOTO, T ;

TERADA, N ;

NISHIZAWA, Y ;

PETROW, V .

INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (03) :393-399

[120]

YAMAOKA M, 1993, CANCER RES, V53, P4262

← 4 5 6 7 8 9 10 11 12 13 →